A group of experts on lower urinary tract dysfunction and cystitis met together to make a consensus report on the assessment of ketamine uropathy (KU) which encompasses ketamine cystitis.
Introduction
As ketamine uropathy (KU) is a relatively new clinical entity since 2007, 1, 2 there is no consensus about the assessment and evaluation for KU to date. Recent publications show that urinary bladder, ureter, and kidney may be damaged in the patients with chronic use of ketamine. 3, 4 In addition, brain, liver, upper gastrointestinal tract, and genital tract functions may be also involved. 5e7 Allergic reaction seems to play an important role in the development of KU. 8 A complete evaluation of the aforementioned organ system is mandatory to provide rapid diagnosis and treatment. A group of experts in lower urinary tract dysfunction and cystitis met together several times to discuss optimal assessment for KU. The draft was presented at the consensus meeting held in Taichung, on April 12, 2015 . The followings are the consensus from the meeting.
Because the ketamine cystitis (KC) shares similar clinical symptoms with interstitial cystitis (IC), recommendations of the assessment for IC patients is adopted for KU. Contracted bladder is present in many cases of KU, part of the concept of neurogenic bladder is adopted. In addition, hydronephrosis and ureteral stricture are encountered in severe cases of KU, upper urinary tract evaluation should be performed. Patients also suffer from hepatobiliary problems, epigastralgia, sexual dysfunction, brain dysfunction. Further assessments are mandatory if the patients have symptoms or dysfunction. Table 1 summarizes essential tests for KU. A structured questionnaire is developed to assist history taking (Appendix). Patients should be queried about ketamine use history, including duration, frequency, dosage, and route of ketamine abuse. Whether the patient is an active abuser or ex-abuser should be clarified. The duration of ketamine cessation must be documented for an exabuser. Other illicit drugs addiction, smoking, betel nut chewing, and alcohol drinking history should also be asked. Up to date, there is no evidence in the relationship between betel nut chewing history and ketamine uropathy. Since this questionnaire is adopted from the case report form of Taiwan Food and Drug Administration (TFDA), we continue to use this item. In this way, we can compare our data with those already registered on TFDA. Hopefully, the relationship between betel nut chewing, a common behavior in Taiwan, can be illustrated later. The interval between the beginning of ketamine abuse and the occurrence of lower urinary tract symptoms (LUTS) should be noted. The severity of LUTS could be assessed by International Prostate Symptoms Score and the "O'Leary-Sant Symptom and Problem Questionnaire". 9 "Pelvic Pain and Urgency/Frequency (PUF) Questionnaire" has been validated for the evaluation of KU in Hong Kong and was shown to correlate well with cystoscopic change, urodynamic abnormalities, and hydronephrosis in patients with KU. 10 Since PUF was not familiar to most Taiwanese doctors and many experts already used International Prostate Symptoms Score (IPSS) and O'Leary-Sant Symptom and Problem questionnaire, which will be continuously recommended in Taiwan. Mood of the patients should be assessed because KU patients may have suicide idea and attempts. A simple tool is provided in the structured questionnaire. Sexual dysfunction has been reported in female ketamine-abusers, 5 and male patients may share similar symptoms. Erectile dysfunction should be asked in men, while problems of sexual arousal, lubrication, orgasm, and dyspareunia should be evaluated in women.
Essential tests for ketamine uropathy
Though most physical examination will be normal, special attention should focus on the nose to see if there is residual white substance around nostril, which may be a sign of continuing use of ketamine. Basic physical examination, including pelvic examination should be performed to exclude other disorders with similar clinical symptoms. Vaginitis, urethritis, prostatitis, urethral diverticulum, and other potential etiology of pain or infection should be excluded through the evaluation. Genital skin lesions should be recorded for the risk for associated sexually transmitted disease.
Urinalysis is a mandatory examination for KU patients, and urine culture should be performed for those with pyuria. For patients with hematuria, urine cytology should be collected to exclude urothelial carcinoma. Renal and liver function test should be checked for all patients to rule out potential renal and hepatic damages. Complete blood-cell count with differential count is ordered to check the presence of eosinophilia and possible anemia. Immunoglobulin E should be checked to rule to allergic reaction. Patients with ketamine cystitis had higher serum IgE than patients with interstitial cystitis/bladder pain syndrome or acute bacterial cystitis, or controls. Serum IgE and the severity of eosinophil infiltration associated with bladder pain severity and small maximal bladder capacity. 8 HIV and VDRL should be checked to rule out coexisted sexually transmitted diseases such as acquired immunodeficiency disease and syphilis.
Uroflowmetry and post-void residual urine (PVR) should be performed. Voided volume plus PVR can be used as a surrogate of bladder capacity which is an important parameter in managing KU. Renosonography should be performed to rule out hydronephrosis. The grade of hydronephrosis must be documented once it was identified. 11 Table 2 lists the optional tests for KU. A voiding diary can be recorded for 48e72 hours in cooperative patients. Maximal voided volume can be a good surrogate of functional bladder capacity since most of the KU patients have low PVR. However, many patients are uncooperative in recording voiding diary. Bladder sonography can be performed to measure bladder wall thickness which may suggest the presence of bladder fibrosis. However, the technical difficulty in measuring bladder wall thickness in a fixed bladder volume makes this test not easy for the KU patients.
Optional tests for ketamine uropathy
Upper urinary tract evaluation such as intravenous urography or computed tomography should be arranged in the presence of hydronephrosis on renosongraphy. 11 Grade and side of hydronephrosis/ureteral stricture should be recorded. Voiding cystourethrography could be performed once vesico-ureteral reflux was suspected as the etiology of hydronephrosis. Since this is an invasive procedure and may cause severe pain, adequate anesthesia and/or pain killer should be provided.
Lower urinary tract can be assessed by a variety of tools. Cystoscopy is not necessary to reach the diagnosis of KU in all patients. The cystoscopic findings of KU patients are non-specific and provide no benefits in confirming the diagnosis. Cystoscopy could be considered when the diagnosis of KU is in doubt. Disorders such as bladder cancer, bladder stones, urethral diverticula, and intravesical foreign bodies could be identified by cystoscopy and the therapeutic approach would then be changed. The role of cystoscopy in KU may be changed after the first report of bladder cancer in a KU patient. 12 Cystoscopy could also be performed in concomitance with bladder hydrodilatation under regional or general anesthesia because many KU patients could not tolerate the procedure when it is performed under local anesthesia. Urodynamic study (UDS) is not necessary for the diagnosis of uncomplicated KU The findings of UDS are inconsistent and could not provide further information for diagnosis or guiding therapy. Furthermore, many patients could not tolerate bladder distension or urethral catheterization during the examination. UDS should be considered only when other lower urinary tract dysfunction was suspected and the treatment would be different once it was identified, such as bladder outlet obstruction or detrusor underactivity. Video-UDS could identify VUR and would be beneficial in differentiating the etiology of hydronephrosis. The potassium sensitivity test (or KCl test) is not recommended in the evaluation of IC patients, as it could not provide information for diagnosis and guiding therapy. It is therefore not suggested in KU patients as the same reasons.
Routine bladder biopsy is an issue to be debated. Generally, histology shows denuded epithelium and inflammation with eosinophil infiltration which may be specific. Bladder biopsy should only be performed when bladder cancer and/or urothelial carcinoma in situ are suspected, particularly after the publication of the first ketamine abuse associated bladder tumors was reported in 2014. 12 Abdominal ultrasonography can be performed in the patients complaining abdominal pain or elevated liver enzymes. Dilatation of bile ducts is quite common. Without knowing the history of ketamine abuse, incision of Sphincter of Oddi had been performed without significant benefits. 7 Panendoscopy may be performed in cases with frequent epigastralgia, though negative findings were usually reported.
Conclusions
We recommend essential and options tests to assess patients with ketamine abuse. Hopefully, patient characteristics can be clarified and different therapeutic strategies for ketamine uropathy can be compared in the future. Then we can have a treatment algorithm for ketamine uropathy soon!
